Giulio Francolini, Vanessa Di Cataldo, Pietro Garlatti, Saverio Caini, Alessio Bruni, Nicola Simoni, Matteo Augugliaro, Roberto Iacovelli, Chiara Ciccarese, Luca Tagliaferri, Nicola Battelli, Gianluca Ingrosso, Angelo Porreca, Gianluca Vullo, Giuseppe Fornarini, Giuseppe Carlo Iorio, Alessia Guarneri, Michele Sisani, Alfio Di Grazia, Lorenzo Livi. "PERSIAN trial (NCT03449719): Predictive features of complete biochemical response within a randomized phase II trial testing apalutamide and stereotactic body radiation therapy for low-burden, metastatic, hormone-sensitive prostate cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.157